Lipae, Samriya .
HRN: 22-45-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/04/2023
01/10/2023
IVT
300mg
Q6
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes